25 XP   0   0   10

Luoxin Pharmaceuticals Group Stock Co Ltd
Buy, Hold or Sell?

Let's analyse Luoxin together

PenkeI guess you are interested in Luoxin Pharmaceuticals Group Stock Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Luoxin Pharmaceuticals Group Stock Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Luoxin Pharmaceuticals Group Stock Co Ltd

I send you an email if I find something interesting about Luoxin Pharmaceuticals Group Stock Co Ltd.

Quick analysis of Luoxin (30 sec.)










What can you expect buying and holding a share of Luoxin? (30 sec.)

How much money do you get?

How much money do you get?
¥0.07
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.04
Expected worth in 1 year
¥2.26
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
¥-0.27
Return On Investment
-6.8%

For what price can you sell your share?

Current Price per Share
¥4.04
Expected price per share
¥3.41 - ¥6.28
How sure are you?
50%

1. Valuation of Luoxin (5 min.)




Live pricePrice per Share (EOD)

¥4.04

Intrinsic Value Per Share

¥-11.12 - ¥-5.37

Total Value Per Share

¥-8.08 - ¥-2.33

2. Growth of Luoxin (5 min.)




Is Luoxin growing?

Current yearPrevious yearGrowGrow %
How rich?$456.9m$654.4m-$197.5m-43.2%

How much money is Luoxin making?

Current yearPrevious yearGrowGrow %
Making money-$169.3m$56.1m-$225.4m-133.1%
Net Profit Margin-34.2%6.3%--

How much money comes from the company's main activities?

3. Financial Health of Luoxin (5 min.)




What can you expect buying and holding a share of Luoxin? (5 min.)

Welcome investor! Luoxin's management wants to use your money to grow the business. In return you get a share of Luoxin.

What can you expect buying and holding a share of Luoxin?

First you should know what it really means to hold a share of Luoxin. And how you can make/lose money.

Speculation

The Price per Share of Luoxin is ¥4.04. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Luoxin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Luoxin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.04. Based on the TTM, the Book Value Change Per Share is ¥-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.27 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.13 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Luoxin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.16-3.9%-0.16-3.9%0.040.9%0.010.3%0.030.7%
Usd Book Value Change Per Share-0.03-0.7%-0.03-0.7%0.040.9%0.061.6%0.041.0%
Usd Dividend Per Share0.020.4%0.020.4%0.010.3%0.010.3%0.020.4%
Usd Total Gains Per Share-0.01-0.2%-0.01-0.2%0.051.2%0.081.9%0.061.4%
Usd Price Per Share1.06-1.06-1.43-1.32-1.33-
Price to Earnings Ratio-6.81--6.81-37.38-22.78-31.08-
Price-to-Total Gains Ratio-112.47--112.47-28.73--14.82--1.99-
Price to Book Ratio2.52-2.52-3.21-4.02-9.40-
Price-to-Total Gains Ratio-112.47--112.47-28.73--14.82--1.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.558328
Number of shares1791
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share-0.030.06
Usd Total Gains Per Share-0.010.08
Gains per Quarter (1791 shares)-16.88140.28
Gains per Year (1791 shares)-67.52561.12
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1126-193-7896465551
2252-387-1461939291112
3378-580-21428913941673
4503-774-28238618592234
5629-967-35048223232795
6755-1160-41857927883356
7881-1354-48667532533917
81007-1547-55477237174478
91133-1740-62286841825039
101259-1934-69096446475600

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%9.01.02.075.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%9.03.00.075.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%12.00.00.0100.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%7.03.00.070.0%9.03.00.075.0%

Fundamentals of Luoxin

About Luoxin Pharmaceuticals Group Stock Co Ltd

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health care services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. was founded in 1998 and is based in Linyi, China.

Fundamental data was last updated by Penke on 2024-04-14 19:42:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Luoxin Pharmaceuticals Group Stock Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Luoxin earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -34.2% means that ¥-0.34 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is -34.2%. The company is making a huge loss. -2
  • The TTM is -34.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-34.2%TTM-34.2%0.0%
TTM-34.2%YOY6.3%-40.4%
TTM-34.2%5Y-0.5%-33.7%
5Y-0.5%10Y7.4%-7.9%
1.1.2. Return on Assets

Shows how efficient Luoxin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -15.1% Return on Assets means that Luoxin generated ¥-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is -15.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-15.1%0.0%
TTM-15.1%YOY4.3%-19.4%
TTM-15.1%5Y2.0%-17.1%
5Y2.0%10Y7.9%-5.9%
1.1.3. Return on Equity

Shows how efficient Luoxin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -38.6% Return on Equity means Luoxin generated ¥-0.39 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is -38.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -38.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-38.6%TTM-38.6%0.0%
TTM-38.6%YOY9.3%-47.9%
TTM-38.6%5Y1.6%-40.2%
5Y1.6%10Y9.6%-8.0%

1.2. Operating Efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Luoxin is operating .

  • Measures how much profit Luoxin makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -39.4% means the company generated ¥-0.39  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is -39.4%. The company is operating very inefficient. -2
  • The TTM is -39.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-39.4%TTM-39.4%0.0%
TTM-39.4%YOY8.0%-47.4%
TTM-39.4%5Y6.7%-46.1%
5Y6.7%10Y15.4%-8.6%
1.2.2. Operating Ratio

Measures how efficient Luoxin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.13 means that the operating costs are ¥2.13 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is 2.126. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.126. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.126TTM2.1260.000
TTM2.126YOY1.393+0.734
TTM2.1265Y1.552+0.575
5Y1.55210Y1.435+0.117

1.3. Liquidity of Luoxin Pharmaceuticals Group Stock Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Luoxin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.08 means the company has ¥1.08 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is 1.079. The company is just able to pay all its short-term debts.
  • The TTM is 1.079. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.079TTM1.0790.000
TTM1.079YOY1.589-0.510
TTM1.0795Y1.484-0.405
5Y1.48410Y2.273-0.789
1.3.2. Quick Ratio

Measures if Luoxin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.20 means the company can pay off ¥0.20 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.202TTM0.2020.000
TTM0.202YOY0.836-0.633
TTM0.2025Y0.656-0.454
5Y0.65610Y0.675-0.019

1.4. Solvency of Luoxin Pharmaceuticals Group Stock Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Luoxin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Luoxin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.59 means that Luoxin assets are financed with 59.2% credit (debt) and the remaining percentage (100% - 59.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is 0.592. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.592. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.592TTM0.5920.000
TTM0.592YOY0.501+0.091
TTM0.5925Y0.470+0.122
5Y0.47010Y0.337+0.133
1.4.2. Debt to Equity Ratio

Measures if Luoxin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 151.3% means that company has ¥1.51 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The MRQ is 1.513. The company is just able to pay all its debts with equity.
  • The TTM is 1.513. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.513TTM1.5130.000
TTM1.513YOY1.086+0.427
TTM1.5135Y0.985+0.528
5Y0.98510Y0.623+0.361

2. Market Valuation of Luoxin Pharmaceuticals Group Stock Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Luoxin generates.

  • Above 15 is considered overpriced but always compare Luoxin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -6.81 means the investor is paying ¥-6.81 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The EOD is -3.585. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.807. Based on the earnings, the company is expensive. -2
  • The TTM is -6.807. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.585MRQ-6.807+3.221
MRQ-6.807TTM-6.8070.000
TTM-6.807YOY37.377-44.183
TTM-6.8075Y22.782-29.589
5Y22.78210Y31.077-8.295
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The EOD is -3.875. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.356. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.356. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.875MRQ-7.356+3.482
MRQ-7.356TTM-7.3560.000
TTM-7.356YOY-80.567+73.210
TTM-7.3565Y-49.344+41.988
5Y-49.34410Y-24.672-24.672
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Luoxin is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Luoxin Pharmaceuticals Group Stock Co Ltd:

  • The EOD is 1.329. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.523. Based on the equity, the company is underpriced. +1
  • The TTM is 2.523. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.329MRQ2.523-1.194
MRQ2.523TTM2.5230.000
TTM2.523YOY3.205-0.682
TTM2.5235Y4.021-1.498
5Y4.02110Y9.397-5.377
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Luoxin Pharmaceuticals Group Stock Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.195-0.1950%0.270-172%0.469-142%0.285-169%
Book Value Per Share--3.0403.0400%3.236-6%2.744+11%2.159+41%
Current Ratio--1.0791.0790%1.589-32%1.484-27%2.273-53%
Debt To Asset Ratio--0.5920.5920%0.501+18%0.470+26%0.337+76%
Debt To Equity Ratio--1.5131.5130%1.086+39%0.985+54%0.623+143%
Dividend Per Share--0.1270.1270%0.090+41%0.097+31%0.124+2%
Eps---1.127-1.1270%0.277-506%0.085-1432%0.213-628%
Free Cash Flow Per Share---1.043-1.0430%-0.129-88%-0.387-63%-0.104-90%
Free Cash Flow To Equity Per Share---0.689-0.6890%0.411-268%-0.051-93%-0.010-99%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.369--------
Intrinsic Value_10Y_min---11.118--------
Intrinsic Value_1Y_max---0.198--------
Intrinsic Value_1Y_min---0.646--------
Intrinsic Value_3Y_max---0.855--------
Intrinsic Value_3Y_min---2.358--------
Intrinsic Value_5Y_max---1.823--------
Intrinsic Value_5Y_min---4.514--------
Market Cap4393863664.640-90%8341815422.7208341815422.7200%15178457574.350-45%11988675334.214-30%11225645644.067-26%
Net Profit Margin---0.342-0.3420%0.063-645%-0.005-99%0.074-562%
Operating Margin---0.394-0.3940%0.080-591%0.067-685%0.154-357%
Operating Ratio--2.1262.1260%1.393+53%1.552+37%1.435+48%
Pb Ratio1.329-90%2.5232.5230%3.205-21%4.021-37%9.397-73%
Pe Ratio-3.585+47%-6.807-6.8070%37.377-118%22.782-130%31.077-122%
Price Per Share4.040-90%7.6707.6700%10.370-26%9.582-20%9.601-20%
Price To Free Cash Flow Ratio-3.875+47%-7.356-7.3560%-80.567+995%-49.344+571%-24.672+235%
Price To Total Gains Ratio-59.239+47%-112.466-112.4660%28.734-491%-14.823-87%-1.987-98%
Quick Ratio--0.2020.2020%0.836-76%0.656-69%0.675-70%
Return On Assets---0.151-0.1510%0.043-453%0.020-873%0.079-291%
Return On Equity---0.386-0.3860%0.093-517%0.016-2484%0.096-503%
Total Gains Per Share---0.068-0.0680%0.361-119%0.567-112%0.409-117%
Usd Book Value--456955275.164456955275.1640%654486090.217-30%477184348.177-4%356868969.924+28%
Usd Book Value Change Per Share---0.027-0.0270%0.037-172%0.065-142%0.039-169%
Usd Book Value Per Share--0.4200.4200%0.447-6%0.379+11%0.298+41%
Usd Dividend Per Share--0.0180.0180%0.012+41%0.013+31%0.017+2%
Usd Eps---0.156-0.1560%0.038-506%0.012-1432%0.029-628%
Usd Free Cash Flow---156711406.307-156711406.3070%-26036301.882-83%-62287045.546-60%-17758784.881-89%
Usd Free Cash Flow Per Share---0.144-0.1440%-0.018-88%-0.053-63%-0.014-90%
Usd Free Cash Flow To Equity Per Share---0.095-0.0950%0.057-268%-0.007-93%-0.001-99%
Usd Market Cap607231958.453-90%1152838891.4201152838891.4200%2097662836.775-45%1656834931.188-30%1551384228.010-26%
Usd Price Per Share0.558-90%1.0601.0600%1.433-26%1.324-20%1.327-20%
Usd Profit---169369808.383-169369808.3830%56122498.071-402%6859635.482-2569%25283128.095-770%
Usd Revenue--495799000.943495799000.9430%895250283.939-45%682311686.494-27%484511716.180+2%
Usd Total Gains Per Share---0.009-0.0090%0.050-119%0.078-112%0.057-117%
 EOD+3 -5MRQTTM+0 -0YOY+5 -305Y+7 -2810Y+9 -26

3.2. Fundamental Score

Let's check the fundamental score of Luoxin Pharmaceuticals Group Stock Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.585
Price to Book Ratio (EOD)Between0-11.329
Net Profit Margin (MRQ)Greater than0-0.342
Operating Margin (MRQ)Greater than0-0.394
Quick Ratio (MRQ)Greater than10.202
Current Ratio (MRQ)Greater than11.079
Debt to Asset Ratio (MRQ)Less than10.592
Debt to Equity Ratio (MRQ)Less than11.513
Return on Equity (MRQ)Greater than0.15-0.386
Return on Assets (MRQ)Greater than0.05-0.151
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Luoxin Pharmaceuticals Group Stock Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.677
Ma 20Greater thanMa 504.443
Ma 50Greater thanMa 1004.397
Ma 100Greater thanMa 2004.899
OpenGreater thanClose4.070
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Income before Tax  127,463596,747724,210-315,279408,93276,270485,201-1,948,141-1,462,940
Net Income  111,346522,605633,950-311,623322,32783,769406,096-1,631,638-1,225,541
EBIT  460,137221,923682,060-265,636416,424103,166519,590-1,932,358-1,412,768
EBITDA  155,044770,754925,798-295,899629,899160,264790,163-1,899,125-1,108,962
Operating Income  125,976640,819766,795-214,950551,845129,904681,749-2,094,517-1,412,768
Tax Provision  16,11754,33870,455-4,12566,330-2,77563,555-268,509-204,954
Income Tax Expense  45,74924,70670,455-4,12566,330-2,77563,555-268,509-204,954
Net Income from Continuing Operations  111,346542,409653,755-311,154342,60179,045421,646-1,679,632-1,257,986
Net Income Applicable to Common Shares  512,315121,635633,950-313,250320,70185,396406,096-1,631,638-1,225,541



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets8,107,824
Total Liabilities4,801,346
Total Stockholder Equity3,174,106
 As reported
Total Liabilities 4,801,346
Total Stockholder Equity+ 3,174,106
Total Assets = 8,107,824

Assets

Total Assets8,107,824
Total Current Assets4,721,893
Long-term Assets3,385,932
Total Current Assets
Cash And Cash Equivalents 1,433,805
Short-term Investments 17,100
Net Receivables 868,642
Inventory 684,986
Other Current Assets 320,335
Total Current Assets  (as reported)4,721,893
Total Current Assets  (calculated)3,324,868
+/- 1,397,025
Long-term Assets
Property Plant Equipment 1,777,273
Goodwill 4,378
Intangible Assets 646,470
Other Assets 979,510
Long-term Assets  (as reported)3,385,932
Long-term Assets  (calculated)3,407,631
+/- 21,699

Liabilities & Shareholders' Equity

Total Current Liabilities4,374,818
Long-term Liabilities426,528
Total Stockholder Equity3,174,106
Total Current Liabilities
Short Long Term Debt 2,378,253
Accounts payable 512,252
Other Current Liabilities 478,640
Total Current Liabilities  (as reported)4,374,818
Total Current Liabilities  (calculated)3,369,144
+/- 1,005,674
Long-term Liabilities
Other Liabilities 172,718
Deferred Long Term Liability 281,373
Long-term Liabilities  (as reported)426,528
Long-term Liabilities  (calculated)454,091
+/- 27,563
Total Stockholder Equity
Common Stock1,087,588
Retained Earnings 1,548,412
Other Stockholders Equity 23,332
Total Stockholder Equity (as reported)3,174,106
Total Stockholder Equity (calculated)2,659,332
+/- 514,774
Other
Capital Stock1,087,588
Common Stock Shares Outstanding 1,087,588
Net Debt 1,135,375
Net Invested Capital 5,743,286
Net Tangible Assets 2,776,918
Net Working Capital 347,074
Property Plant and Equipment Gross 2,818,536



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
271,941
372,308
2,667,700
3,073,693
3,640,177
812,893
898,927
1,401,732
7,460,560
7,721,700
9,496,830
8,107,824
8,107,8249,496,8307,721,7007,460,5601,401,732898,927812,8933,640,1773,073,6932,667,700372,308271,941
   > Total Current Assets 
0
0
1,959,637
2,198,954
2,594,325
3,189,061
477,179
3,922,338
4,873,967
4,883,337
6,368,388
4,721,893
4,721,8936,368,3884,883,3374,873,9673,922,338477,1793,189,0612,594,3252,198,9541,959,63700
       Cash And Cash Equivalents 
65,303
64,179
187,004
160,512
605,333
140,127
125,760
323,353
1,108,523
1,287,575
2,001,722
1,433,805
1,433,8052,001,7221,287,5751,108,523323,353125,760140,127605,333160,512187,00464,17965,303
       Short-term Investments 
0
0
0
0
0
6
1,296
100,000
106,841
0
12,579
17,100
17,10012,5790106,841100,0001,296600000
       Net Receivables 
43,395
57,374
316,961
407,725
626,725
930,893
129,295
1,500,740
2,255,160
2,519,020
3,335,653
868,642
868,6423,335,6532,519,0202,255,1601,500,740129,295930,893626,725407,725316,96157,37443,395
       Other Current Assets 
1,338
12,637
77,478
125,073
70,725
74,218
-18,316
846,105
274,369
271,486
289,323
320,335
320,335289,323271,486274,369846,105-18,31674,21870,725125,07377,47812,6371,338
   > Long-term Assets 
0
0
0
0
0
286,492
421,748
584,504
2,586,593
2,841,298
3,128,442
3,385,932
3,385,9323,128,4422,841,2982,586,593584,504421,748286,49200000
       Property Plant Equipment 
60,358
65,302
599,324
764,177
862,429
983,339
226,151
1,487,473
1,754,938
1,921,466
2,071,069
1,777,273
1,777,2732,071,0691,921,4661,754,9381,487,473226,151983,339862,429764,177599,32465,30260,358
       Goodwill 
0
0
165
165
165
165
0
6,385
6,385
8,810
9,757
4,378
4,3789,7578,8106,3856,385016516516516500
       Long Term Investments 
0
0
41,000
41,000
70,287
89,335
0
0
0
0
0
0
00000089,33570,28741,00041,00000
       Intangible Assets 
6,126
74,755
17
73,164
4,057
74,462
191,391
186,941
513,859
601,879
650,295
646,470
646,470650,295601,879513,859186,941191,39174,4624,05773,1641774,7556,126
       Long-term Assets Other 
0
0
0
0
0
286,492
421,748
28,833
13,720
17,445
58,059
41,385
41,38558,05917,44513,72028,833421,748286,49200000
> Total Liabilities 
120,072
166,773
581,469
726,477
967,764
114,559
144,742
491,846
3,498,806
3,371,341
4,761,040
4,801,346
4,801,3464,761,0403,371,3413,498,806491,846144,742114,559967,764726,477581,469166,773120,072
   > Total Current Liabilities 
120,072
166,444
561,089
706,097
878,238
1,364,156
139,819
2,697,641
2,950,916
2,967,476
4,007,277
4,374,818
4,374,8184,007,2772,967,4762,950,9162,697,641139,8191,364,156878,238706,097561,089166,444120,072
       Short-term Debt 
0
0
0
0
0
0
0
110,000
0
0
0
0
0000110,0000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
110,000
780,880
837,404
1,934,109
2,378,253
2,378,2531,934,109837,404780,880110,0000000000
       Accounts payable 
71,281
76,181
165,957
179,119
130,188
227,758
83,919
636,951
1,094,241
851,575
899,768
512,252
512,252899,768851,5751,094,241636,95183,919227,758130,188179,119165,95776,18171,281
       Other Current Liabilities 
27,319
15,550
331,428
474,920
704,058
1,041,516
42,405
711,142
334,137
382,505
395,030
478,640
478,640395,030382,505334,137711,14242,4051,041,516704,058474,920331,42815,55027,319
   > Long-term Liabilities 
0
0
0
0
0
2,693
4,922
244,628
547,889
404,626
753,763
426,528
426,528753,763404,626547,889244,6284,9222,69300000
       Other Liabilities 
0
0
20,380
20,380
89,526
136,285
4,922
68,569
83,908
101,299
129,503
172,718
172,718129,503101,29983,90868,5694,922136,28589,52620,38020,38000
       Deferred Long Term Liability 
0
0
0
0
0
194
101
186,135
236,593
322,424
371,450
281,373
281,373371,450322,424236,593186,13510119400000
> Total Stockholder Equity
151,869
205,536
2,082,747
2,343,420
2,653,153
698,334
754,185
909,886
3,679,079
4,040,506
4,384,587
3,174,106
3,174,1064,384,5874,040,5063,679,079909,886754,185698,3342,653,1532,343,4202,082,747205,536151,869
   Common Stock
54,945
75,000
60,960
60,960
60,960
60,960
200,000
1,075,472
1,435,176
1,467,223
1,463,689
1,087,588
1,087,5881,463,6891,467,2231,435,1761,075,472200,00060,96060,96060,96060,96075,00054,945
   Retained Earnings 
72,836
53,666
1,990,648
2,251,321
2,561,370
2,727,208
297,794
1,898,434
2,191,445
2,437,654
2,788,900
1,548,412
1,548,4122,788,9002,437,6542,191,4451,898,434297,7942,727,2082,561,3702,251,3211,990,64853,66672,836
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
0
0
0
0
-316
-215
0
12,090
52,457
-1,096
-2,743
23,332
23,332-2,743-1,09652,45712,0900-215-3160000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,644,434
Cost of Revenue-1,383,701
Gross Profit260,733260,733
 
Operating Income (+$)
Gross Profit260,733
Operating Expense-2,861,194
Operating Income-1,216,761-2,600,461
 
Operating Expense (+$)
Research Development124,137
Selling General Administrative983,321
Selling And Marketing Expenses-
Operating Expense2,861,1941,107,458
 
Net Interest Income (+$)
Interest Income16,296
Interest Expense-90,792
Other Finance Cost-12,408
Net Interest Income-62,088
 
Pretax Income (+$)
Operating Income-1,216,761
Net Interest Income-62,088
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,173,889-1,216,761
EBIT - interestExpense = -90,792
-957,685
-866,893
Interest Expense90,792
Earnings Before Interest and Taxes (EBIT)--1,083,097
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,173,889
Tax Provision--112,929
Net Income From Continuing Ops-1,060,960-1,060,960
Net Income-957,685
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-62,088
 

Technical Analysis of Luoxin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Luoxin. The general trend of Luoxin is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Luoxin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Luoxin Pharmaceuticals Group Stock Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.8 < 6.22 < 6.28.

The bearish price targets are: 3.41.

Tweet this
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Luoxin Pharmaceuticals Group Stock Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Luoxin Pharmaceuticals Group Stock Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current macd is -0.14028516.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Luoxin price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Luoxin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Luoxin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current adx is 20.90.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Luoxin shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Luoxin Pharmaceuticals Group Stock Co Ltd. The current sar is 4.41526775.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current rsi is 37.68. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Relative Strength Index (RSI) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Luoxin Pharmaceuticals Group Stock Co Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Luoxin price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Stochastic Oscillator ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current cci is -138.78138781.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Commodity Channel Index (CCI) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current cmo is -32.42069667.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Chande Momentum Oscillator (CMO) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Luoxin Pharmaceuticals Group Stock Co Ltd. The current willr is -82.27848101.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Williams %R ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Luoxin Pharmaceuticals Group Stock Co Ltd.

Luoxin Pharmaceuticals Group Stock Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current atr is 0.22015911.

Luoxin Pharmaceuticals Group Stock Co Ltd Daily Average True Range (ATR) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current obv is -213,207,558.

Luoxin Pharmaceuticals Group Stock Co Ltd Daily On-Balance Volume (OBV) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Luoxin Pharmaceuticals Group Stock Co Ltd. The current mfi is 50.57.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Luoxin Pharmaceuticals Group Stock Co Ltd Daily Money Flow Index (MFI) ChartLuoxin Pharmaceuticals Group Stock Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Luoxin Pharmaceuticals Group Stock Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Luoxin Pharmaceuticals Group Stock Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Luoxin Pharmaceuticals Group Stock Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.677
Ma 20Greater thanMa 504.443
Ma 50Greater thanMa 1004.397
Ma 100Greater thanMa 2004.899
OpenGreater thanClose4.070
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Luoxin with someone you think should read this too:
  • Are you bullish or bearish on Luoxin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Luoxin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Luoxin Pharmaceuticals Group Stock Co Ltd

I send you an email if I find something interesting about Luoxin Pharmaceuticals Group Stock Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Luoxin Pharmaceuticals Group Stock Co Ltd.

Receive notifications about Luoxin Pharmaceuticals Group Stock Co Ltd in your mailbox!